EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)

Clinical trial NCT05723107 · RECRUITING

Trial details

NCT number: NCT05723107
Sponsor: NYU Langone Health
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2023-03-31
Primary completion: 2027-11-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.